Northern Trust’s Beam Therapeutics BEAM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$19.7M Buy
825,580
+16,633
+2% +$462K ﹤0.01% 1690
2025
Q4
$22.4M Sell
808,947
-45,397
-5% -$1.16M ﹤0.01% 1590
2025
Q3
$20.7M Buy
854,344
+25,836
+3% +$514K ﹤0.01% 1658
2025
Q2
$14.1M Sell
828,508
-25,041
-3% -$436K ﹤0.01% 1867
2025
Q1
$16.7M Buy
853,549
+113,043
+15% +$2.96M ﹤0.01% 1738
2024
Q4
$18.4M Buy
740,506
+49,415
+7% +$1.26M ﹤0.01% 1746
2024
Q3
$16.9M Buy
691,091
+33,709
+5% +$871K ﹤0.01% 1728
2024
Q2
$15.4M Sell
657,382
-1,798
-0.3% -$44.2K ﹤0.01% 1721
2024
Q1
$21.8M Sell
659,180
-9,362
-1% -$292K ﹤0.01% 1535
2023
Q4
$18.2M Buy
668,542
+13,934
+2% +$346K ﹤0.01% 1678
2023
Q3
$15.7M Buy
654,608
+29,646
+5% +$795K ﹤0.01% 1710
2023
Q2
$20M Buy
624,962
+16,998
+3% +$552K ﹤0.01% 1585
2023
Q1
$18.6M Sell
607,964
-4,886
-0.8% -$193K ﹤0.01% 1604
2022
Q4
$24M Buy
612,850
+8,410
+1% +$377K 0.01% 1414
2022
Q3
$28.8M Buy
604,440
+42,337
+8% +$2.42M 0.01% 1218
2022
Q2
$21.8M Buy
562,103
+101,060
+22% +$4.02M ﹤0.01% 1466
2022
Q1
$26.4M Sell
461,043
-18,915
-4% -$1.24M ﹤0.01% 1477
2021
Q4
$38.2M Buy
479,958
+1,061
+0.2% +$90.8K 0.01% 1299
2021
Q3
$41.7M Buy
478,897
+25,323
+6% +$2.54M 0.01% 1230
2021
Q2
$58.4M Buy
453,574
+50,817
+13% +$4.05M 0.01% 1008
2021
Q1
$32.2M Sell
402,757
-24,400
-6% -$2.32M 0.01% 1483
2020
Q4
$34.9M Buy
427,157
+45,101
+12% +$2.22M 0.01% 1375
2020
Q3
$9.41M Buy
382,056
+214,813
+128% +$5.33M ﹤0.01% 2145
2020
Q2
$4.68M Buy
167,243
+36,217
+28% +$780K ﹤0.01% 2568
2020
Q1
$2.36M Buy
+131,026
New +$2.85M ﹤0.01% 2763

Other funds holding BEAM